Delivery Order SPE2DB25D3005-SPE2DB25FQKBL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,690.14 to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid medication primarily used for severe acne treatment, and this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Isotretinoin 30 mg capsules (30-count unit) with a ceiling value of $5,913.36. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was competitively awarded without a set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a potent...
- The Defense Logistics Agency awarded a delivery order valued at $20,726.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. Isotretinoin...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) valued at $18,281.62 under a firm fixed-price contract with no set-aside designation. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Isotretinoin is a prescription medication primarily used for treating...
- The Defense Logistics Agency awarded a delivery order valued at $1,173.84 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Isotretinoin is a potent retinoid medication primarily used for severe acne treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $35,121.23 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,093.00 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,645.60. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,004.48 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 40 mg capsules (30-count) with a firm fixed price and no set-aside designation. The contract was awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction within AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQKBLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,383.74 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Isotretinoin is a potent oral retinoid primarily used for the treatment of severe acne and represents a specialized pharmaceutical product critical to military healthcare operations. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a prime vendor for federal medical procurement across the Defense Health Agency and broader military healthcare systems. The company maintains an extensive portfolio of pharmaceutical and medical supply deliveries through competitive awards with the DLA, demonstrating consistent capability to fulfill diverse federal medical requirements ranging from specialty medications to generic drugs and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/25/25 |